Clinical aspects of metabolomics

Methods in Pharmacology and Toxicology

Volumn 17, Issue , 2012, Pages 29-60

  Bousamra II, Michael ^a   Day, Jamie ^b   Fan, Teresa Whei Mei ^b   Kloecker, Goetz ^a   Lane, Andrew N ^a   Miller, Donald M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CANCER CELL; CELL METABOLISM; CLINICAL CHEMISTRY; CLINICAL RESEARCH; CONCEPT ANALYSIS; EXPERIMENTAL DESIGN; FUNDING; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; ISOTOPE LABELING; ISOTOPE TRACING; MEDICAL ETHICS; MEDICOLEGAL ASPECT; METABOLOMICS; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PATIENT SELECTION; POWER ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TISSUE PREPARATION; TISSUE PRESERVATION;

EID: 84863200535     PISSN: 15572153     EISSN: 19406053     Source Type: Book Series    
DOI: 10.1007/978-1-61779-618-0_3     Document Type: Article

References (40)

1. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48: 23.21-32.31.
2. Fan TW-M, Lane AN, Higashi RM. The promise of metabolomics in cancer molecular therapeutics. Curr Opin Mol Ther. 2004;6:584-92. (Pubitemid 40074978)
3. Serkova NJ, Spratlin JL, Eckhardt SG. NMRbased metabolomics: translational application and treatment of cancer. Curr Opin Mol Ther. 2007;9:572-85. (Pubitemid 350179097)
4. Di BuonoM, Jones PJH, Beaumier L,Wykes LJ. Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis. J Lipid Res. 2000;41:1516-23.
5. Mason GF, Petersen KF, de Graaf RA, Kanamatsu T, Otsuki T, Rothman DL. A comparison of C-13 NMRmeasurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of 1-C-13 glucose. Brain Res Protoc. 2002;10:181-90. (Pubitemid 36143919)
6. Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL. The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci USA. 2005;102:5588-93. (Pubitemid 40530301)
7. Fan TW, Lane AN. Structure-based profiling of metabolites and isotopomers by NMR. Prog NMR Spectrosc. 2008;52:69-117. (Pubitemid 351175632)
8. Mayes PD, Bender DA. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, editors. Harpers illustrated biochemistry. 26th ed. McGraw-Hill: New York; 2003.
9. Lane AN, Fan TW-M, Higashi RM. Stable isotope assisted metabolomics in cancer research. IUBMB Life. 2008;60:124-9.
10. Lindon JC, Holmes E, Nicholson JK. Toxicological applications of magnetic resonance. Prog Nucl Magn Reson Spectrosc. 2004; 45:109-43.
11. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 2005;18:143-62. (Pubitemid 40716122)
12. Lindon JC, Nicholson JK, Everett JR. Annual reports on NMR spectroscopy, vol. 38. San Diego: Academic Press; 1999. p. 1-88.
13. Fan TWM, Lane AN, Higashi RM. The promise of metabolomics in cancer molecular therapeutics. Curr Opin Mol Ther. 2004;6:584-92. (Pubitemid 40074978)
14. Griffin JL, Kauppinen RA. Tumour metabolomics in animal models of human cancer. J Proteome Res. 2007;6:498-505. (Pubitemid 46340153)
15. Ippolito JE, Xu J, Jain SJ, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci U S A. 2005;102:9901-6. (Pubitemid 40993665)
16. Zimmermann D, Hartmann M, Moyer MP, Nolte J, Baumbach JI. Determination of volatile products of human colon cell line metabolism by GC/MS analysis. Metabolomics. 2007;3:13-7. (Pubitemid 46443553)
17. Kind T, Tolstikov V, Fiehn O, Weiss RH. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem. 2007;363:185-95. (Pubitemid 46428214)
18. Beger RD, Schnackenberg LK, Holland RD, Li DH, Dragan Y. Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma. Metabolomics. 2006;2:125-34. (Pubitemid 44473571)
19. Hoffmeister KN, Falet H, Toker A, Barkalow KL, StosselDagger TP, Hartwig JH. Mechanisms of cold-induced platelet actin assembly. J Biol Chem. 2001;276:24751-9.
20. Tablin F, Oliver AE, Walker NJ, Crowe LM, Crowe JH. Membrane phase transition of intact human platelets: correlation with cold-induced activation. J Cell Physiol. 1996;168:305-13. (Pubitemid 26308742)
21. Saude EJ, Sykes BD. Urine stability for metabolomic studies: effects of preparation and storage. Metabolomics. 2007;3:19-27. (Pubitemid 46453528)
22. Saude EJ, Adamko D, Rowe BH, Marrie T, Sykes BD. Variation of metabolites in normal human urine. Metabolomics. 2007;3:439-51. (Pubitemid 350090674)
23. Viant MR, Ludwig C, Rhodes S, Günther UL, Allaway D. Validation of a urine metabolome fingerprint in dog for phenotypic classification. Metabolomics. 2007;3:453-63. (Pubitemid 350090675)
24. Wilson JF. Health Insurance Portability and Accountability Act Privacy Rule causes ongoing concerns among clinicians and researchers. Ann Intern Med. 2006;145:313-6. (Pubitemid 46768620)
25. Harrigan GG, Goodacre R, editors. Metabolic profiling: its role in biomarker discovery and gene function analysis. New York: Springer; 2003.
26. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6:469-79. (Pubitemid 46340151)
27. Kettaneh N, Berglund A, Wold S. PCA and PLS with very large data sets. Comput Stat Data Anal. 2005;48:69-85.
28. Rossner B. Fundamentals of biostatistics. 6th ed. Belmont: Thomson; 2006.
29. Fan TWM. Recent advances in profiling plant metabolites by multinuclear and multidimensional NMR. In: Shachar-Hill Y, Pfeffer PE, editors. Nuclear magnetic resonance in plant biology, Vol 16. American Society of Plant Physiologists, Rockville; 1996. p. 181-254.
30. Fan TWM. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc. 1996;28:161-219.
31. Lane AN, Fan TW. Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics. 2007;3:79-86. (Pubitemid 46863862)
32. Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol Cancer. 2009;8:41.
33. Lane AN, Fan TW, Higashi RM, Tan J, Bousamra M, Miller DM. Prospects for clinical cancer metabolomics using stable isotope tracers. J Exp Mol Pathol. 2009;86:165-73.
34. Fan TW-M, Lane AN, Higashi M, Bousamra M, Kloecker G, Miller DM. Erlotinib-sensitive and resistant lung tumors show radically different metabolic profiles. Exp Mol Pathol. 2009;87:83-6.
35. Lane AN, Fan TW-M, Bousamra II M, Higashi RM, Yan J, Miller DM. Clinical applications of stable isotope-resolved metabolomics (SIRM) in non-small cell lung cancer. Omics. 2011;15:173-182.
36. Edelman RJ, Gandara DR. Lung Cancer. In: Casciato DA, editor. Manual of clinical oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2004.
37. Griffin JL, Nicholls AW, Daykin CA, Heald S, Keun HC, Schuppe-Koistinen I, Griffiths JR, Cheng LL, Rocca-Serra P, Rubtsov DV, et al. Standard reporting requirements for biological samples in metabolomics experiments: mammalian/ in vivo experiments. Metabolomics. 2007;3:179-88. (Pubitemid 47470686)
38. Goodacre R, Broadhurst D, Smilde AK, Kristal BS, Baker JD, Beger R, Bessant C, Connor S, Calmani G, Craig A, et al. Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics. 2007;3:231-41. (Pubitemid 47470692)
39. Boros LG. Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic network. Metabolomics. 2005;1:11-5. (Pubitemid 40973870)
40. Harrigan GG, Brackett DJ, Boros LG. Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini Rev Med Chem. 2005;5:13-20. (Pubitemid 40124839)